tiprankstipranks
pc:altrx

ALTR

Food & Beverage
ALTR is a pioneering beverage technology company based in Phoenix, specializing in the development of premium low-alcohol drinks. Utilizing its proprietary "Flavor-First" technology, ALTR preserves the full sensory experience of beverages while reducing their alcohol content, catering to the growing consumer demand for mindful drinking options.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$5M
Total Amount Raised$5M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 09, 2025
Seed Round
$5.00M
―

Investors

Investor Name
Funding Round
Demeter
Seed Round
Suntory Global Spirits
Seed Round
Techmind
Seed Round
AZ Venture Capital Inc
Seed Round
FTW Ventures
Seed Round
Bluestein Ventures
Seed Round
Solvable
Seed Round
Xinomavro
Seed Round

Related News and Analysis

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

New updates have been reported about Talkiatry. Talkiatry has entered a strategic partnership with AMGA to expand in-network...
6m ago
TALKI
Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

New updates have been reported about Fibr AI. Fibr AI has introduced two web personalization capabilities aimed at...
6m ago
FIBRA
TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

New updates have been reported about TransPerfect. TransPerfect has acquired Rome-based Studio Emme SpA, a long-established dubbing and...
7m ago
TRA2H
Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

New updates have been reported about Lettuce Financial. Lettuce Financial plans to acquire Carry’s retirement and investing platform,...
7m ago
LETTU
BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

New updates have been reported about BQP. BQP is positioning itself at the center of New York’s quantum...
7m ago
BQPXX
Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

New updates have been reported about Cala Health. Cala Health has received U.S. Food and Drug Administration clearance...
7m ago
CALAH
Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics will showcase pivotal first-in-human and preclinical data for...
18m ago
VER0L
Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics has obtained a $28 million capital infusion from...
18m ago
VER0L
Sonire Therapeutics Raises $18 Million to Drive Breakthrough HIFU Pancreatic Cancer Program and U.S. Expansion

Sonire Therapeutics Raises $18 Million to Drive Breakthrough HIFU Pancreatic Cancer Program and U.S. Expansion

New updates have been reported about Sonire Therapeutics. Sonire Therapeutics has secured $18 million in Series A funding...
18m ago
SONIR
Gallant Advances Feline OA Stem Cell Program With Positive Data and FDA Fast-Track Pathway

Gallant Advances Feline OA Stem Cell Program With Positive Data and FDA Fast-Track Pathway

New updates have been reported about Gallant. Gallant has reported positive pilot data for its intravenous uterine-derived mesenchymal...
30m ago
GAL3M